ctDNA-guided surveillance and treatment monitoring in breast cancer
About this episode
The episode discusses advances in ctDNA-informed monitoring and treatment strategies in breast cancer with leading experts.
In this week’s VJOncology podcast, we are delighted to bring you the latest advances in circulating tumor DNA (ctDNA)-informed monitoring and follow-up strategies in breast cancer. Join leading experts Wolfgang Janni, MD, University of Ulm, Ulm, Germany, Arielle Medford, MD, Massachusetts General Cancer Center, Boston, MA, Seth Wander, MD, PhD, Massachusetts General Hospital, Boston, MA, and Rinath Jeselsohn, MD, Dana-Farber Cancer Institute, Boston, MA, as they explore cutting-edge data from key studies including SURVIVE, LEADER, a Phase I/II trial of vepdegestrant, and PACE. Together, they discuss the evolving role of circulating tumor DNA in detecting molecular relapse, guiding early intervention strategies, monitoring treatment response, and predicting resistance across early and advanced ER+/HER2-negative and HR+/HER2-negative breast cancer settings.
More episodes of VJOncology Podcast
- Bladder Cancer Awareness Month: subtypes, diagnostics & breakthroughs
- Beyond EGFR: navigating molecular targets and emerging therapies in advanced NSCLC
- Head and neck cancer awareness month: key trials and evolving treatment strategies
- Lung cancer highlights from the 24th BTOG annual conference
- Immuno-oncology updates from 12th Immunotherapy of Cancer Conference
- Top updates from ASCO GU 2026: latest trials in prostate, kidney, and bladder cancer
Explore listener stats, chart rankings, contacts and more on the VJOncology Podcast podcast page.